Gene · 171221
NIH grants1,959
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,959
Download this page as JSON| Grant | Title | DNAJB1P1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA096500 | Role of KSHV Viral Proteins in Signaling and Pathogenesis | 2 | 2022 |
| R01CA161976 | Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy | 2 | 2022 |
| R01CA214916 | Control of mutant p53 stability via the mevalonate pathway-DNAJA1 axis | 2 | 2022 |
| R01EY012682 | Molecular Mechanism of Photoreceptor G Protein Signaling | 2 | 2022 |
| R01GM132606 | Determining the scope of prenylatable protein sequences | 2 | 2022 |
| R37GM056433 | Protein Folding in the Eukaryotic Cytosol | 2 | 2022 |
| T32DK061296 | Renal and Epithelial Biology Training Program | 2 | 2022 |
| T32GM007288 | Medical Scientist Training Program | 2 | 2022 |
| T32GM065086 | Chemistry-Biology Interface Training Grant | 2 | 2022 |
| U01AG061356 | Multi-omic network-directed proteoform discovery, dissection and functional validation to prioritize novel AD therapeutic targets | 2 | 2022 |
| U54CA163059 | Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma | 2 | 2022 |
| DP5OD023118 | Antibody display libraries for precision screening of antibody immune responses to SARS-CoV-2 | 1 | 2022 |
| I01BX001655 | Analysis and therapy of age-dependent proteostasis failure in neurodegeneration | 1 | 2022 |
| K01HL140271 | The role of epigenetic transcriptional memory in monocyte-macrophage cells and cardiovascular disease risk | 1 | 2022 |
| P01AG031862 | Epigenetics of Aging and Age-Associated Diseases | 1 | 2022 |
| P01HL091842 | Origins of Cystic Fibrosis Airway Disease | 1 | 2022 |
| P30DK079310 | George M. O'Brien Kidney Center at Yale | 1 | 2022 |
| R01AG027237 | The role of SIRT6 posttranslational modifications in aging and genome stability | 1 | 2022 |
| R01AG062254 | Inference of Common Pathways Underlying Neurodegeneration & Other Age-Progressive Diseases | 1 | 2022 |
| R01AG062335 | Elucidating the Molecular Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/171221/grants?page=24